Searched for
BAYER PHARMACEUTICALS PRIVATE LTD.
Pricing depends on the country, Bayer looks at affordability: ExecutiveIndia has evolved significantly in the clinical trial setting...we have a significant number of patients and trials running in IndiaAshraf ...- Bayer acquires remaining 25% stake in Bayer Zydus Pharma Pvt Ltd to secure full ownershipBayer Pharmaceuticals Private Limited and Zydus Lifesciences Limited have concluded their joint venture, Bayer Zydus Pharma Private Limited...
- MNC pharma body OPPI appoints Anil Matai as new director generalThe Organisation of Pharmaceutical Producers of India (OPPI) has appointed Anil Matai as its director general. Matai has extensive experien...
- Bayer steps up India R&D, clinical trials"Our strategy for India in pharmaceuticals is to continue to make significant investments, we believe that India is a growing market with a...
- Sustainability: Time to Walk the talk
- Aurobindo Pharma to buy US animal health firm Cronus for Rs 420 crHyderabad-based Cronus is engaged in development, manufacturing and sale of veterinary pharmaceutical products and has a large exposure in ...
- Twenty five stocks in focus on Thursday, 20 October 2016The Nifty50 made a reversal candlestick chart pattern on the daily charts indicating that market is lacking momentum and further up move fr...
- Fifteen stocks in focus on Friday, 23 September 2016The Indian market is expected to open flat. Here is a list of top fifteen stocks that are likely to be in focus today.
- Sun Pharmaceuticals among bidders for Bayer’s dermatology brandsPrivate equity players KKR, Nordic Capital, Bain Capital, Blackstone and Cinven may also be looking at buying the same assets.
- Fifteen stocks in focus in Tuesday's tradeIndian markets are expected to trade in a range. Here is a list of fifteen stocks which are likely to remain in focus today.
- Sensex rangebound ahead of F&O expiry; top ten stocks in focusAt 10:00 a.m.; Sensex was at 8,265.65, down 1.1 points or 0.01 per cent. It touched a high of 8,286.40 and a low of 8,255.35 in trade today.
- Ten stocks in focus in Wednesday morning tradeIndian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.
- Fulford India divests consumer care biz to Bayer Pharmaceuticals Private LtdBayer will completely take over the marketing and distribution of the consumer care products with effect from January 1, 2015, it added.
- Will India achieve pharma vision 2020?The government is committed to making India one of the world’s leading destinations for end-to-end drug discovery and innovation by 2020.
- Patented drug launches could be delayed in India: DeloitteLaunch of patented drugs in India could be delayed due to the government's "thought process on linking patented drug prices to the country'...
- Piramal acquires Decision Resources Group, US analytics company, for $635 mnPiramal bought DRG from private equity firm Providence, which exited the company by selling its 100% holding.
- Cadila Healthcare Q4 net zooms by 50.69 pc to Rs 178.97 crCadila Healthcare today said its consolidated net profit rose by 50.69 per cent to Rs 178.97 crore for the fourth quarter ended March 31, 2...
- Reckitt Benckiser may snap up Paras PharmaA leading UK-based company is all set to buy Ahmedabad-based Paras Pharmaceuticals, a person close to the development said.
- Emami frontrunner to bag Paras Pharma for about Rs 3,000 crEmami, which has shown a keen interest in Paras Pharma ever since the beginning of the bidding game, is understood to be shelling out aroun...
- Ranbaxy considers acquisitions in USRanbaxy Laboratories Ltd, India's biggest drugmaker, considers acquisitions aimed at expanding operations in the US, south and central Amer...
Load More
